Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : F

Records returned : 108 (on 28 May 2025 at 06:03:32).

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important

NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.

 
Links :
SPC
NFD1
NHSE
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important

NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.

 
Links :
SPC
NFD1
NHSE
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important

NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.

 
Links :
SPC
NFD1
NHSE
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important

NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.

 
Links :
SPC
NFD1
NHSE
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important

NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.

 
Links :
SPC
NFD1
NHSE
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
NHS England - specialist centres only
 
Links :
SPC
NHSE
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important

NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.

 
Links :
SPC
NFD1
NHSE
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important

Follow local guidelines on the use of antimicrobials

 
Links :
SPC
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Preferred
 
Links :
Indication :
Status :
Red
Formulations :
  • Modified release tablets
Restrictions / Comments:

Important
Specialist centre only
Commissioned by NHSE from specialist centres only.
 
Links :
SPC
NHSE
Status :
Red
Formulations :
  • Intravitreal injection
Restrictions / Comments:

 
Links :
SPC
ICB
NICE
Indication :
Status :
Red
Formulations :
  • Intravitreal injection
Restrictions / Comments:

Important
For place in therapy see guidelines on PAD
 
Links :
Status :
Red
Formulations :
  • Intravitreal injection
Restrictions / Comments:

 
Links :
SPC
ICB
NICE
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
For patients where allopurinol is not tolerated or contraindicated
 
Links :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Gel
Restrictions / Comments:

 
Links :
SPC
NFD1
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
To be initiated at Specialist centres (NHSE)
 
Links :
SPC
NHSE
NICE
Indication :
Status :
Blue
Formulations :
  • Capsules
  • Tablets
Restrictions / Comments:

Important
Primary care prescribing on recommendation from specialist team for Familial hypercholesterolaemia and hypertriglyceridaemia.
 
Links :
Indication :
Status :
Blue
Formulations :
  • Patches
Restrictions / Comments:

Important

Prescribe by brand in Primary Care. Not for use in opioid naïve patients. Limited place in therapy - on specialist advice only

 
Links :
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
See separate listing for use in assisted ventilation and anaesthesia
 
Links :
Indication :
Status :
Red
Formulations :
  • Injection
  • Nasal spray
Restrictions / Comments:

Important
100mcg in 2ml injection used intranasally in paediatrics for painful procedures.
 
Links :
Guidelines SPC
CD
Un
Indication :
Status :
Non Formulary
Formulations :
  • Buccal tablets
  • Buccal/sublingual
  • Lozenges
  • Nasal spray
  • Sublingual tablets
Restrictions / Comments:

Important
Immediate release fentanyl preparations are non-formulary for all pain indications EXCEPT for breakthrough pain in patients receiving opioid therapy for cancer pain.
 
Links :
Guidelines SPC
CD
NFD1
Indication :
Status :
Blue
Formulations :
  • Buccal tablets
  • Lozenges
  • Sublingual tablets
Restrictions / Comments:

Important

Immediate release fentanyl preparations are only on formulary for breakthrough pain in patients receiving opioid therapy for cancer pain.

 
Links :
SPC
CD
Indication :
Status :
Blue
Formulations :
  • Nasal spray
Restrictions / Comments:

Important

Immediate release fentanyl preparations are only on formulary for breakthrough pain in patients receiving opioid therapy for cancer pain.

 
Links :
SPC
CD
Indication :
Status :
Red
Formulations :
  • Infusion
Restrictions / Comments:

Important
For use in PCA/PIEB during labour
 
Links :
SPC
Un
Status :
Red
Formulations :
  • Intravenous infusion
  • Intravenous injection (IV)
Restrictions / Comments:

Important

2nd line. Preferred option in pregnancy or under 18 years.
Ferric derisomaltose is 1st line.

 
Links :
SPC
Status :
Red
Formulations :
  • Intravenous injection (IV)
Restrictions / Comments:

Preferred
 
Links :
SPC
Status :
Green (see narrative)
Formulations :
  • Capsules
Restrictions / Comments:

Important

Ferric Maltol 30mg capsules – reserved as a last option before referral and if parenteral iron is being considered

 
Links :
SPC
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred

Prescribing for children: Express the dose in terms of elemental iron and iron salt and select the most appropriate preparation; specify both the iron salt and formulation on the prescription.

 
Links :
SPC
Status :
Green
Formulations :
  • Oral solution
Restrictions / Comments:

Important

Prescribing for children: Express the dose in terms of elemental iron and iron salt and select the most appropriate preparation; specify both the iron salt and formulation on the prescription.

 
Links :
SPC
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred

300mg tablets.
Prescribing for children: Express the dose in terms of elemental iron and iron salt and select the most appropriate preparation; specify both the iron salt and formulation on the prescription.

 
Links :
SPC
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred

Prescribing for children: Express the dose in terms of elemental iron and iron salt and select the most appropriate preparation; specify both the iron salt and formulation on the prescription.

 
Links :
SPC
Status :
Non Formulary
Formulations :
  • Modified release tablets
Restrictions / Comments:

Important

Prescribing for children: Express the dose in terms of elemental iron and iron salt and select the most appropriate preparation; specify both the iron salt and formulation on the prescription.

BNF: Modified-release preparations of iron are licensed for once-daily dosage, but have no therapeutic advantage and should not be used. 

 
Links :
SPC
Status :
Green (see narrative)
Formulations :
  • Not Specified
Restrictions / Comments:

Important
3rd line - for patients requiring more potent treatment
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
2nd line to loratadine / cetirizine tablets. 120mg tablets available to buy over the counter.180mg tablets NOT licensed for allergic rhinitis. 30mg reserved for paediatrics.
 
Links :
Status :
Red
Restrictions / Comments:

 
Links :
SPC
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important

NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.

 
Links :
SPC
NFD1
NHSE
Status :
Green
Formulations :
  • Oral suspension
  • Tablets
Restrictions / Comments:

Important
Granules (for oral suspension) should be used in patients requiring a liquid preparation. Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. For any patient requiring a liquid preparation, fidaxomicin granules should be prescribed. The APC notes that although current NICE guidelines recommend vancomycin first line, it is recognised that this was based on cost and in exceptional cases when a liquid is required, fidaxomicin granules are appropriate to prescribe as a licensed preparation that supports timely treatment.
 
Links :
SPC
R
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important
Ulcerative colitis - adults only
 
Links :
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important
Preferred

Refer to St Luke's Protocols for current indications and further detail.

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
NHSE
NICE
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
SPC
NFD1
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Preferred
 
Links :
SPC
Status :
Amber
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
Indication :
Status :
Red
Formulations :
  • Capsules
Restrictions / Comments:

 
Links :
SPC
NHSE
NICE
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
NHS England - specialist centres only
 
Links :
SPC
NHSE
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Specialist initiation and at least one month supply before transfer to primary care
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Unlicensed. For use or advice by cardiology consultants only.
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Capsules
  • Oral suspension
Restrictions / Comments:

Important
Contra-indicated in Penicillin Allergy. Follow local guidelines on the use of antimicrobials.
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Contra-indicated in Penicillin Allergy. Follow local guidelines on the use of antimicrobials.
 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
See PAD for guidance on providing reserve supplies for dosing during acute illness
2nd line option. Requests for primary care prescribing on recommendation from specialist endocrinology team only.
 
Links :
SPC
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
For advice on dosing of glucocorticoids during acute illness please see PAD page
2nd line option. Requests for primary care prescribing on recommendation from specialist endocrinology team only.
 
Links :
SPC
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Postural hypotension - off label use. Specialist team initiation and supply for at least 1 month before transfer of prescribing to primary care.
 
Links :
SPC
NICE
Un
Status :
Red
Formulations :
  • Intravenous injection (IV)
Restrictions / Comments:

Important
https://www.toxbase.org/
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Ear drops
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Restricted to use in patients who are intolerant or refractory to other treatment options
 
Links :
Status :
Red
Formulations :
  • Intravitreal implant
Restrictions / Comments:

Important
Ophthalmology specialists only. In patients who have failed to respond to prior treatments.
 
Links :
SPC
ICB
NICE
R
Indication :
Status :
Red
Formulations :
  • Intravitreal implant
Restrictions / Comments:

Important
Ophthalmology specialists only.
 
Links :
SPC
ICB
NICE
Status :
Red
Formulations :
  • Eye drops (preservative free
  • unit dose)
Restrictions / Comments:

 
Links :
SPC
Status :
Red
Formulations :
  • Eye drops (preservative free
  • unit dose)
Restrictions / Comments:

Important
Lidocaine 4% with Fluorescein 0.25%
 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Eye drops
Restrictions / Comments:

Important
Short-term use only. Primary Care prescribing on specialist recommendation.
 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Flixotide Accuhaler - specialist paediatric recommendation. 50 and 100mcg strength only.

Children only - ICS alone not recommended in adults with asthma.

Prescribe by BRAND

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Flixotide Evohaler - specialist paediatric recommendation. 50 and 125 mcg strength only.

Children only - ICS alone not recommended in adults with asthma.

Prescribe by BRAND

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Nasal spray
Restrictions / Comments:

Important

Mometasone Furoate is the preferred intranasal steroid for allergic rhinitis. If fluticasone is required, prescribe as fluticasone furoate in Primary Care (less costly option). Prices may vary in secondary care. NOTE: ASPH restrict fluticasone furoate to use in paediatrics due to smaller nozzle size.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Nasal spray
Restrictions / Comments:

Important

Mometasone Furoate is the preferred intranasal steroid for allergic rhinitis. If fluticasone is required, prescribe as fluticasone furoate in Primary Care (less costly option). Prices may vary in secondary care. NOTE: ASPH recommend fluticasone furoate in paediatrics due to smaller nozzle size.

 
Links :
Indication :
Status :
Green
Formulations :
  • Nasal spray
Restrictions / Comments:

Important
Off-label use. Only the fluticasone drops are licensed for nasal polyps.
 
Links :
SPC
Un
Indication :
Status :
Green
Formulations :
  • Nasal drops (unit dose)
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Nasal spray
Restrictions / Comments:

Important
Reserved for use where monotherapy is inadequate. Not 1st line.
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Flutiform 50/5 - For children aged 5 to 11 years needing ICS/LABA, unable to use DPI.

Not recommended for use in adults.

Prescribe by BRAND

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Flutiform 125/5 and 250/10 - on request from specialist team only.

Very high carbon footprint.

Prescribe by BRAND.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Salmeterol containing preparations not recommended in asthma guideline.

Increased risk of adrenal suppression in children.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Salmeterol containing preparations not recommended in asthma guideline.

Increased risk of adrenal suppression in children.

Not for initiation in new patients.

 
Links :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Not recommended in Surrey Heartlands COPD guidelines.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Salmeterol containing preparations not recommended in asthma guideline.

Increased risk of adrenal suppression in children.

Not for initiation in new patients

 
Links :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Not for initiation in new patients.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Seretide Evohaler 50/25 - for children aged 5 to 11 years needing ICS/LABA, unable to use DPI.

Not recommended for use in adults.

Prescribe by BRAND.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Salmeterol containing preparations not recommended in asthma guideline.

Increased risk of adrenal suppression in children.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Relvar Ellipta 92/22 and 184/22 - higher dose ICS LABA for specialist recommendation only.

Once daily formulation.

Prescribe by BRAND.

 
Links :
Status :
Green
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Relvar Ellipta 92/22

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Green
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important

5mg tablets.

 
Links :
SPC
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Preferred
https://www.toxbase.org/. Unlicensed drug
 
Links :
SPC
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important
Unstable angina and NSTEMI. Caution - potential for latex reactions in allergic patients
 
Links :
SPC
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important
Caution - potential for latex reactions in allergic patients.
 
Links :
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Capsules
Restrictions / Comments:

Important

ONLY after single anastomosis duodenal illeal bypass with sleeve (SADI-S) or duodenal switch surgery

 
Links :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Specialist centres only
 
Links :
SPC
NHSE
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Easyhaler Formoterol

LABA monotherapy no longer recommended for asthma or COPD.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

LABA monotherapy no longer recommended for asthma or COPD.

Not to be initiated in new patients.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

LABA monotherapy no longer recommended for asthma or COPD.

Not for initiation in new patients.

 

 
Links :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Oxis Turbohaler

LABA monotherapy no longer recommended for asthma or COPD.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Restricted Antimicrobial - requires GUM Specialist approval
 
Links :
SPC
NHSE
R
Status :
Red
Formulations :
  • Intravenous infusion
Restrictions / Comments:

Important
RSCH Oncology Team only
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important

Restricted antimicrobial - to be used under advice of Microbiology consultant

 
Links :
SPC
R
Indication :
Status :
Red
Formulations :
  • Intravitreal injection
Restrictions / Comments:

Important
Consultant ophthalmologists only
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Granules
Restrictions / Comments:

Important
Follow local guidelines on the use of antimicrobials.
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Infusion
Restrictions / Comments:

Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
 
Links :
SPC
R
Indication :
Status :
Red
Formulations :
  • Intravenous infusion
Restrictions / Comments:

Important
Will need tertiary centre approval before Blueteq/funding released
 
Links :
SPC
NHSE
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important

Haematology use only - treating treating refractory chronic immune thrombocytopenia as per NICE TA835

 
Links :
Indication :
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

 
Links :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Off-label. Use if inadequate response to standard acute migraine treatments
 
Links :
SPC
Un
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Not 1st line. Generic sumatriptan, naratriptan, rizatripan, zolmitriptan are preferred.
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Injection
  • Oral solution
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Status :
Green
Formulations :
  • Eye drops
Restrictions / Comments:

Important
1% modified-release eye drops
 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Suspension
  • Tablets
Restrictions / Comments:

Important
Follow local guidelines on the use of antimicrobials. Use in primary care when indicated by microbiology eg on culture results. Note - licensed products are being discontinued in 2025.
 
Links :
SPC
R